Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$11.8M Buy
907,496
+599,564
+195% +$9.04M 0.01% 1318
2014
Q2
$6.15M Buy
307,932
+213,679
+227% +$3.16M ﹤0.01% 1774
2014
Q1
$1.79M Buy
94,253
+91,087
+2,877% +$1.73M ﹤0.01% 2885
2013
Q4
$54K Sell
3,166
-601
-16% -$9.2K ﹤0.01% 6857
2013
Q3
$59K Buy
3,767
+767
+26% +$9.74K ﹤0.01% 6650
2013
Q2
$36K Buy
+3,000
New +$30.7K ﹤0.01% 7159

Other funds holding INSM

UBS's INSM Position: Q3 2014 in Review

UBS increased its Insmed (INSM) stake by 195% in Q3 2014, buying an estimated $9.04M and bringing the position to 907,496 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1318.

UBS first reported a position in INSM in Q2 2013 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold INSM as of Q3 2014.

  • UBS held 907,496 shares of Insmed worth $11.8M as of Q3 2014.
  • UBS bought 599,564 Insmed shares in Q3 2014, an estimated $9.04M.
  • Insmed made up 0.01% of UBS's portfolio in Q3 2014, its #1318 holding.
  • UBS first reported a position in Insmed in Q2 2013 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Insmed as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.